2026 UN High-Level Meeting on HIV/AIDS
The IFPMA delivered a statement at the 2026 UN High-Level Meeting on HIV/AIDS, emphasizing the role of pharmaceutical innovation in ending the epidemic by 2030. The organization called for continued investment in R&D, equitable access, and collaboration between the private sector and governments.
Why it matters
Global health initiatives rely on the intersection of intellectual property, private sector innovation, and public policy to manage long-term health crises.
Share Topics Infectious diseases On 22 June 2026, IFPMA delivered a statement at the UN High-Level Meeting on HIV/AIDS in New York.
The text reflects the official position of an industry trade group regarding global health policy.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in